ResearchMoz

Insight Report: Angel Investors

WealthInsight
Published Date » 2014-04-16
No. Of Pages » 65
 
     
 
  Synopsis  
  
     
  The report provides market analysis and insights, including:  
     
 
 
 Insights on the HNW VC/AI market and the prevailing trends in each region. 
 Insight into investment focal-points of VCs and AIs by industry. 
 Analysis of the key trends, drivers and challenges that affect angel investors and venture capitalists, and a focus on the role of various entities in the VC/AI market. 
 The report is based on a unique analysis of WealthInsight’s proprietary HNWI database which comprises 95,000 individuals and focuses on four regions: the Americas, Europe, Asia-Pacific, and the Middle East and Africa. 
 
 
   
  Executive summary  
   
 Venture Capital (VC) and Angel Investments (AI) are rapidly becoming an investment of choice...
Table of contents

1 Introduction
1.1 What is this Report About? 
1.2 Definitions

2 Executive Summary

3 Global Snapshot
3.1 The VC/AI Market – A Snapshot
3.2 Market Attractiveness for Angel investors
3.3 Global Angel Investment and Venture Capital Investment Trends
3.4 Findings from the HNWI database
3.5 Case Study: Tiger of Money – the Startup Game
3.6 Case Study: Innovation Warehouse – One-Stop Solution
3.7 Roles of Various Entities in Improving the Private Equity Market

4 Key Drivers for the Angel Investment Market
4.1 The Americas
4.2 Asia-Pacific
4.3 Europe
4.4 The Middle East and Africa

5 Current Trends in the Angel Investment Market
5.1 The Americas
5.2 Asia-Pacific
5.3 Europe
5.4 The Middle East and Africa

6 Key Challenges in the Angel Investment Market
6.1 The Americas
6.2 Asia-Pacific
6.3 Europe
6.4 The Middle East & Africa

7 About WealthInsight

List of Tables


List of Figures

Upcoming Reports:

Greece: fertilizers market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the fertilizers market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the fertilizers market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the...
Spinal Non-Fusion Devices Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Spinal implants are devices used to treat deformity, provide stability and strengthen the spine.These devices are broadly segmented as fusion and non-fusion spinal devices. Non-fusion spinal surgery is expected to grow during the study period, even though fusion devices account for the largest market share. Non-fusion spinal surgery’s growth is assisted by engineers and medical practitioners collaborativelycreating devices that can be implanted without fusion in human bodywhich helps to retain flexibility and movement of patients post-surgery.Spinal non-fusion devices market can be...
Greece: market of plastic stoppers, lids, caps and other closures
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the plastic stoppers, lids, caps and other closures market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the plastic stoppers, lids, caps and other closures market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...